Why ASML Stock Lost 18% in July

ASML finished the month down 18% (S&P Global), with shares dropping 7.4% on July 1 after reports Anthropic was working on its own AI chip and then sliding another 5.8% on July 27 over fears China is building competing deep-ultraviolet lithography machines. The stock briefly rebounded after Q2 results topped guidance: revenue rose 21.2% YoY to €9.33B and EPS improved from €5.90 to €7.58, while full-year revenue guidance was raised from €36B–€40B to €43B–€45B. Net impact is a mixed setup: strong results and guidance versus sustained competitive/geopolitical demand risk for customers.

Analysis

The market is treating ASML like a generic AI beta name, but the business is really a capex tollbooth on leading-edge wafer intensity. A custom-chip cycle at hyperscalers is not inherently bearish for the tool stack; if anything, ASIC migration can sustain foundry demand and keep TSMC/INTC capex elevated. The more relevant threat is China localization, which would pressure ASML’s China replacement and service mix first; that is a margin/mix issue over 12-24 months, not an immediate impairment of the EUV moat.

The structural risk is that investors are compressing the multiple on headline risk before they have evidence of a real order-cycle inflection. The key watch item is not the stock reaction, but whether order intake, backlog conversion, or China commentary deteriorates over the next 1-2 quarters. If those hold, the selloff is more likely a sentiment reset than a fundamental reset; if they roll over, the downside can extend because ASML is valued on visibility, not just growth.

Contrarian view: the consensus may be overpricing the competitive threat from Chinese DUV development because a domestic tool that exists on paper is not the same as a tool that ships at usable yield, uptime, and service economics. Even partial substitution would mostly cap low-end China growth, while the real earnings engine remains tied to non-China leading-edge nodes. The move looks more overdone than underdone unless we see a second-leg deterioration in guidance or a meaningful drop in bookings.

Key Decisions for Investors

• Buy ASML on additional weakness over the next 1-3 weeks; use a 3-6 month horizon and target a rebound toward pre-selloff valuation if order intake holds. Falsifier: a cut to FY guidance or a material slowdown in net bookings.
• Use a relative-value long ASML / short NVDA pair for 3-6 months if AI-headline volatility keeps blurring equipment beneficiaries with chip demand names. Risk: if AI capex broadly rolls over, both legs can weaken; size modestly.
• Set an alert on ASML’s next earnings for China revenue mix, backlog conversion, and commentary on High-NA adoption. If China share or order growth falls sharply, the trade thesis changes from headline overreaction to real revenue erosion.
• For more aggressive investors, buy a 3-6 month ASML call spread after volatility remains elevated for another session or two; this expresses mean reversion without overpaying for upside. Stop if the stock fails to hold post-earnings support and guidance indicators weaken.